BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16712515)

  • 1. The early events of alpha-synuclein oligomerization revealed by photo-induced cross-linking.
    Li HT; Lin XJ; Xie YY; Hu HY
    Protein Pept Lett; 2006; 13(4):385-90. PubMed ID: 16712515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different species of alpha-synuclein oligomers induce calcium influx and seeding.
    Danzer KM; Haasen D; Karow AR; Moussaud S; Habeck M; Giese A; Kretzschmar H; Hengerer B; Kostka M
    J Neurosci; 2007 Aug; 27(34):9220-32. PubMed ID: 17715357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biophysical properties and cellular toxicity of covalent crosslinked oligomers of α-synuclein formed by photoinduced side-chain tyrosyl radicals.
    Borsarelli CD; Falomir-Lockhart LJ; Ostatná V; Fauerbach JA; Hsiao HH; Urlaub H; Paleček E; Jares-Erijman EA; Jovin TM
    Free Radic Biol Med; 2012 Aug; 53(4):1004-15. PubMed ID: 22771470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenolic compounds prevent the oligomerization of α-synuclein and reduce synaptic toxicity.
    Takahashi R; Ono K; Takamura Y; Mizuguchi M; Ikeda T; Nishijo H; Yamada M
    J Neurochem; 2015 Sep; 134(5):943-55. PubMed ID: 26016728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexation of NAC-Derived Peptide Ligands with the C-Terminus of α-Synuclein Accelerates Its Aggregation.
    Jha NN; Ranganathan S; Kumar R; Mehra S; Panigrahi R; Navalkar A; Ghosh D; Kumar A; Padinhateeri R; Maji SK
    Biochemistry; 2018 Feb; 57(5):791-804. PubMed ID: 29286644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-Synuclein oligomerization and aggregation: All models are useful but only if we know what they model: This is the reply to a comment "Alpha-synuclein oligomerization and aggregation: A model will always be a model" on the original article "Monitoring alpha-synuclein oligomerization and aggregation using bimolecular fluorescence complementation assays: What you see is not always what you get". The articles are accompanied by a Preface "How good are cellular models?".
    Lashuel HA
    J Neurochem; 2021 May; 157(4):891-898. PubMed ID: 33336386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring alpha-synuclein oligomerization and aggregation using bimolecular fluorescence complementation assays: What you see is not always what you get.
    Frey B; AlOkda A; Jackson MP; Riguet N; Duce JA; Lashuel HA
    J Neurochem; 2021 May; 157(4):872-888. PubMed ID: 32772367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of photochemical cross-linking to the study of oligomerization of amyloidogenic proteins.
    Lopes DH; Sinha S; Rosensweig C; Bitan G
    Methods Mol Biol; 2012; 849():11-21. PubMed ID: 22528080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Parkinson's disease-associated H50Q mutation accelerates α-Synuclein aggregation in vitro.
    Ghosh D; Mondal M; Mohite GM; Singh PK; Ranjan P; Anoop A; Ghosh S; Jha NN; Kumar A; Maji SK
    Biochemistry; 2013 Oct; 52(40):6925-7. PubMed ID: 24047453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acidic pH on the stability of α-synuclein dimers.
    Lv Z; Krasnoslobodtsev AV; Zhang Y; Ysselstein D; Rochet JC; Blanchard SC; Lyubchenko YL
    Biopolymers; 2016 Oct; 105(10):715-24. PubMed ID: 27177831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Terminal Acetylation Preserves α-Synuclein from Oligomerization by Blocking Intermolecular Hydrogen Bonds.
    Bu B; Tong X; Li D; Hu Y; He W; Zhao C; Hu R; Li X; Shao Y; Liu C; Zhao Q; Ji B; Diao J
    ACS Chem Neurosci; 2017 Oct; 8(10):2145-2151. PubMed ID: 28741930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The N-terminal residues 43 to 60 form the interface for dopamine mediated α-synuclein dimerisation.
    Leong SL; Hinds MG; Connor AR; Smith DP; Illes-Toth E; Pham CL; Barnham KJ; Cappai R
    PLoS One; 2015; 10(2):e0116497. PubMed ID: 25679387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive fluorescence polarization technique for rapid screening of alpha-synuclein oligomerization/fibrillization inhibitors.
    Luk KC; Hyde EG; Trojanowski JQ; Lee VM
    Biochemistry; 2007 Nov; 46(44):12522-9. PubMed ID: 17927212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic and membrane-facilitated α-synuclein oligomerization revealed by label-free detection through solid-state nanopores.
    Hu R; Diao J; Li J; Tang Z; Li X; Leitz J; Long J; Liu J; Yu D; Zhao Q
    Sci Rep; 2016 Feb; 6():20776. PubMed ID: 26865505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidating the Role of Site-Specific Nitration of α-Synuclein in the Pathogenesis of Parkinson's Disease via Protein Semisynthesis and Mutagenesis.
    Burai R; Ait-Bouziad N; Chiki A; Lashuel HA
    J Am Chem Soc; 2015 Apr; 137(15):5041-52. PubMed ID: 25768729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of alpha-synuclein aggregation and inhibition of pore-like oligomer development by beta-synuclein.
    Tsigelny IF; Bar-On P; Sharikov Y; Crews L; Hashimoto M; Miller MA; Keller SH; Platoshyn O; Yuan JX; Masliah E
    FEBS J; 2007 Apr; 274(7):1862-77. PubMed ID: 17381514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-speed atomic force microscopy reveals structural dynamics of α-synuclein monomers and dimers.
    Zhang Y; Hashemi M; Lv Z; Williams B; Popov KI; Dokholyan NV; Lyubchenko YL
    J Chem Phys; 2018 Mar; 148(12):123322. PubMed ID: 29604892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.
    El-Agnaf OM; Paleologou KE; Greer B; Abogrein AM; King JE; Salem SA; Fullwood NJ; Benson FE; Hewitt R; Ford KJ; Martin FL; Harriott P; Cookson MR; Allsop D
    FASEB J; 2004 Aug; 18(11):1315-7. PubMed ID: 15180968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of α-Synuclein Fibril Inhibition by Four Different Amyloid Inhibitors.
    Jha NN; Kumar R; Panigrahi R; Navalkar A; Ghosh D; Sahay S; Mondal M; Kumar A; Maji SK
    ACS Chem Neurosci; 2017 Dec; 8(12):2722-2733. PubMed ID: 28872299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis for preventing α-synuclein aggregation by a molecular tweezer.
    Acharya S; Safaie BM; Wongkongkathep P; Ivanova MI; Attar A; Klärner FG; Schrader T; Loo JA; Bitan G; Lapidus LJ
    J Biol Chem; 2014 Apr; 289(15):10727-10737. PubMed ID: 24567327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.